Library / regulatory-reference
Uganda: National Drug Authority (NDA)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The National Drug Authority, known as the NDA, is Uganda's national regulator for medicines, established under the National Drug Policy and Authority Act of 1993.
Uganda's medicines supply is predominantly imported, and the authority's registration, licensing and inspection decisions determine what reaches patients across the country.
How products enter the market
Medicines require registration after evaluation of quality, safety and efficacy, and manufacturers, importers, wholesalers and retail pharmacies are licensed and inspected.
Post-market work includes pharmacovigilance and market surveillance, supported by the authority's own quality-control laboratory, which has been internationally recognized for medicines testing.
Regional and international role
The authority participates in East African regional regulatory cooperation, including joint assessment and reliance arrangements among neighboring regulators.
Its laboratory's international standing makes Uganda a reference point for quality-control capacity building in the region.
Using this profile
The authority publishes guidelines, registers and safety alerts in English through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the NDA illustrates the laboratory-anchored regulator: a national authority whose internationally recognized testing capacity underpins its market supervision.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.